Discontinuation of β-blocker therapy in stabilised patients after acute myocardial infarction (SMART-DECISION): rationale and design of the randomised controlled trial

Introduction There is a lack of evidence to support the effectiveness of prolonged β-blocker therapy after stabilisation of patients with acute myocardial infarction (AMI) without heart failure (HF) or left ventricular systolic dysfunction.Methods and analysis The SMart Angioplasty Research Team: DE...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jin-Ok Jeong, Juhee Cho, Chang-Hwan Yoon, Sung Gyun Ahn, Cheol Woong Yu, Hyun Kuk Kim, Danbee Kang, Eliseo Guallar, Juwon Kim, Ki Hong Choi, Taek Kyu Park, Jeong Hoon Yang, Young Bin Song, Hyeon-Cheol Gwon, Yong Hwan Park, Jang Hyun Cho, Joo-Yong Hahn, Chang-Wook Nam, Joon-Hyung Doh, Jihoon Kim, Weon Kim, Sung-Ho Her, Eun-Seok Shin, Jin-Yong Hwang, Juhan Kim, Jong Pil Park, Sang Min Kim, Byung-Ryul Cho, Seung-Jae Joo, Jon Suh, Woo Jang, Seong-Hoon Lim, Sang-Rok Lee, Byung Jin Kim, Kyu Tae Park, Joo-Myung Lee, Seung Hyuk Choi
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2024-08-01
Series:	BMJ Open
Online Access:	https://bmjopen.bmj.com/content/14/8/e086971.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Discontinuation of β-blocker therapy in stabilised patients after acute myocardial infarction (SMART-DECISION): rationale and design of the randomised controlled trial

Similar Items